Altimmune expands AdCOVID manufacturing collaboration with Lonza
AdCOVID is a COVID-19 vaccine candidate that is administered via nasal spray.
AdCOVID is a COVID-19 vaccine candidate that is administered via nasal spray.
The company expects to generate an EBITDA margin before special items of around 27 percent in 2021.
Subscribe To Our Newsletter & Stay Updated